Department of Gastroenterological Surgery Division, Yokohama City University School of Medicine, 3 Chome-9 Fukuura, Kanazawa Ward, Yokohama, Kanazawa, 236-0004, Japan.
Department of Surgery, Saiseikai Yokohamashi Nanbu Hospital, 3 Chome-2-10 Konandai, Konan Ward, Yokohama, Kanagawa, 234-0054, Japan.
World J Surg. 2023 Jul;47(7):1772-1779. doi: 10.1007/s00268-023-06966-x. Epub 2023 Mar 31.
Although previous studies have noted the potential benefit of early drain removal (EDR) after pancreatoduodenectomy (PD), there is a paucity of data on the timing of drain removal utilizing a national database that reflect the "real world" setting. Given the ongoing controversy related to PD drain use and management, we sought to define trends in drain use among a large national cohort, as well as identify factors associated with EDR following PD.
The ACS NSQIP targeted pancreatectomy database was used to identify patients who underwent PD between 2014 and 2020. The trend in proportion of patients with EDR (removal ≤ POD3) as well as predictors of EDR were assessed. Risk-adjusted postoperative outcomes were evaluated by multivariable regression analysis.
Among 14,356 patients, 16.2% of patients (N = 2324) experienced EDR, and the proportion of patients with EDR increased by 68% over the study period (2014: 10.9% vs. 2020: 18.3%, p < 0.001). Higher drain fluid amylase on POD1-3 [LogWorth (LW) = 44.3], operative time (LW = 33.2), and use of minimally invasive surgery (LW = 14.0) were associated with EDR. Additionally, EDR was associated with decreased risk of overall and serious morbidity, PD-related morbidity (e.g., pancreatic fistula), reoperation, prolonged length of stay and readmission (all p < 0.05).
Routine drain placement remains a common practice among most surgeons. EDR following PD increased over time was associated with lower post-operative complications and shorter LOS. Despite evidence that EDR was safe and may even be associated with lower complications, only 1 in 6 patients were managed with EDR.
尽管先前的研究已经注意到在胰十二指肠切除术(PD)后早期拔除引流管(EDR)的潜在益处,但利用反映“真实世界”情况的全国性数据库来研究引流管拔除时机的数据却很少。鉴于与 PD 引流管使用和管理相关的持续争议,我们试图确定在大型全国队列中引流管使用的趋势,并确定与 PD 后 EDR 相关的因素。
利用 ACS NSQIP 靶向胰腺切除术数据库,确定 2014 年至 2020 年间接受 PD 的患者。评估 EDR 患者比例的趋势(≤PD3 日拔除)以及 EDR 的预测因素。通过多变量回归分析评估风险调整后的术后结局。
在 14356 例患者中,16.2%(N=2324)的患者经历了 EDR,并且在研究期间 EDR 的患者比例增加了 68%(2014 年:10.9%;2020 年:18.3%,p<0.001)。术后第 1-3 天引流液淀粉酶升高(LogWorth [LW] = 44.3)、手术时间延长(LW = 33.2)和微创外科手术的使用(LW = 14.0)与 EDR 相关。此外,EDR 与总发病率和严重发病率、PD 相关发病率(如胰瘘)、再次手术、住院时间延长和再入院率降低相关(均 p<0.05)。
常规放置引流管仍然是大多数外科医生的常见做法。随着时间的推移,PD 后 EDR 的增加与术后并发症减少和住院时间缩短相关。尽管有证据表明 EDR 是安全的,甚至可能与更低的并发症相关,但只有 1/6 的患者接受了 EDR 治疗。